Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makishima

Showing results (721-730 of 737) with videos related to

Pageof 74
Sort By:
Leukemia|December 3, 2025
DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective studyCarmelo Gurnari, Hideki Makishima, Arda Durmaz, et al.
The Lancet. Haematology|October 28, 2023
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMTCarmelo Gurnari, Marie Robin, Lucy A Godley, et al.
Cancer Discovery|April 7, 2020
Combined Cohesin-RUNX1 Deficiency Synergistically Perturbs Chromatin Looping and Causes Myelodysplastic SyndromesYotaro Ochi, Ayana Kon, Toyonori Sakata, et al.
Blood Advances|March 29, 2023
Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasmsYasuhito Nannya, Magnus Tobiasson, Shinya Sato, et al.
Cancer Cell|June 15, 2021
Molecular classification and diagnostics of upper urinary tract urothelial carcinomaYoichi Fujii, Yusuke Sato, Hiromichi Suzuki, et al.
Nature Genetics|December 20, 2016
Dynamics of clonal evolution in myelodysplastic syndromesHideki Makishima, Tetsuichi Yoshizato, Kenichi Yoshida, et al.
Cancer Cell|April 30, 2015
Inherited and Somatic Defects in DDX41 in Myeloid NeoplasmsChantana Polprasert, Isabell Schulze, Mikkael A Sekeres, et al.
Nature|January 4, 2019
Age-related remodelling of oesophageal epithelia by mutated cancer driversAkira Yokoyama, Nobuyuki Kakiuchi, Tetsuichi Yoshizato, et al.
Leukemia|May 17, 2019
Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profilingYosaku Watatani, Yasuharu Sato, Hiroaki Miyoshi, et al.
Nature Chemical Biology|October 6, 2015
New IDH1 mutant inhibitors for treatment of acute myeloid leukemiaUjunwa C Okoye-Okafor, Boris Bartholdy, Jessy Cartier, et al.
Pageof 74

Showing results (721-730 of 737) with videos related to

Sort By:
Pageof 74
Leukemia|December 3, 2025
DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective studyCarmelo Gurnari, Hideki Makishima, Arda Durmaz, et al.
The Lancet. Haematology|October 28, 2023
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMTCarmelo Gurnari, Marie Robin, Lucy A Godley, et al.
Cancer Discovery|April 7, 2020
Combined Cohesin-RUNX1 Deficiency Synergistically Perturbs Chromatin Looping and Causes Myelodysplastic SyndromesYotaro Ochi, Ayana Kon, Toyonori Sakata, et al.
Blood Advances|March 29, 2023
Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasmsYasuhito Nannya, Magnus Tobiasson, Shinya Sato, et al.
Cancer Cell|June 15, 2021
Molecular classification and diagnostics of upper urinary tract urothelial carcinomaYoichi Fujii, Yusuke Sato, Hiromichi Suzuki, et al.
Nature Genetics|December 20, 2016
Dynamics of clonal evolution in myelodysplastic syndromesHideki Makishima, Tetsuichi Yoshizato, Kenichi Yoshida, et al.
Cancer Cell|April 30, 2015
Inherited and Somatic Defects in DDX41 in Myeloid NeoplasmsChantana Polprasert, Isabell Schulze, Mikkael A Sekeres, et al.
Nature|January 4, 2019
Age-related remodelling of oesophageal epithelia by mutated cancer driversAkira Yokoyama, Nobuyuki Kakiuchi, Tetsuichi Yoshizato, et al.
Leukemia|May 17, 2019
Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profilingYosaku Watatani, Yasuharu Sato, Hiroaki Miyoshi, et al.
Nature Chemical Biology|October 6, 2015
New IDH1 mutant inhibitors for treatment of acute myeloid leukemiaUjunwa C Okoye-Okafor, Boris Bartholdy, Jessy Cartier, et al.
Pageof 74